Tag: VE416

Bacteria

Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...

News Wire -
First clinical study of a bacterial consortium for treating food allergy will initially be studied in patients with history of peanut allergy.
Vedanta Immunomodulator

Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million

Dave Bloom -
Product candidate being developed may safely induce permanent tolerance to food allergens.

Connect with Us

40,874FansLike
1,046FollowersFollow
2,786FollowersFollow
5,649FollowersFollow
45SubscribersSubscribe
SnackSafely.com

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

©2019 SnackSafely.com Inc. All rights reserved.